Patents
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
12/2004
12/29/2004EP1490049A1 Citalopram for the treatment of elevated blood pressure
12/29/2004EP1490048A1 Pharmaceutical composition for preventing or treating respiratory disease
12/29/2004EP1490047A2 Certain pharmaceutically useful substituted aminoalkyl heterocycles
12/29/2004EP1490043A2 Spirocyclic amides as cannabinoid receptor modulators
12/29/2004EP1373259B1 Pyridazinone aldose reductase inhibitors
12/29/2004EP1250316B1 Method for producing n-alkoxy-n-alkylamides
12/29/2004EP1206442A4 Substituted chiral allosteric hemoglobin modifiers
12/29/2004EP0986545B1 Non-steroidal (hetero) cyclically substituted acylanilides with mixed gestagen and androgen activity
12/29/2004CN1558899A Spirocyclic 3-phenyl-3-substituted 4-ketolactams and 4-ketolactones
12/29/2004CN1558898A Antiviral agent
12/29/2004CN1557812A Potassium sodium dehydroandroandrographolide succinates and their preparations
12/29/2004CN1182127C Substituted 2-benzo [c] furanone compound, its preparing process and pharmaceutical composition containing same
12/29/2004CN1182103C Novel ethylamine derivatives
12/29/2004CA2529949A1 Antiviral compounds and methods
12/29/2004CA2529154A1 Novel compounds that modulate ppar.gamma. type receptors, and use thereof in cosmetic or pharmaceutical compositions
12/29/2004CA2525713A1 Benzofuran inhibitors of factor viia
12/28/2004US6835832 Catalytic hydrogenation
12/28/2004US6835747 Ft-0554a substances and process for the preparation thereof
12/28/2004US6835495 Pentacyclic anion salts or tetrazapentalene derivatives and their uses as ionic conducting materials
12/28/2004CA2331297C Hygromycin a derivatives
12/23/2004WO2004110989A1 N-hydroxy-7-(arylamino)heptanamide derivatives useful for treating hyper-proliferative disorders
12/23/2004WO2004110986A1 Benzamide derivative or salt thereof
12/23/2004WO2004110974A1 Matrix metalloproteinase inhibitors
12/23/2004WO2004110348A2 Saururus cernuus compounds that inhibit cellular responses to hypoxia
12/23/2004WO2004031109A3 Chiral diols, their manufacture and ligands and catalysts derived therefrom
12/23/2004WO2003095438A9 Substituted phenylacetamides and their use as glucokinase activators
12/23/2004US20040260095 human immunodeficiency virus (HIV) protease inhibitors; AIDS; prophylaxis
12/23/2004US20040260038 Produced by reacting a thiol and a maleic acid compound, especially thio derivatives with succinic anhydride, succinate or bissuccinimide groups; useful as thermally dissociatable curing agents, particularly for epoxy resins and polyurethanes
12/23/2004US20040259941 Aminoalkyl-benzofuran-5-ol compounds for the treatment of glaucoma
12/23/2004US20040259940 Precipitation from mother liquors by adding bases or acid addition salts to solution of citalopram
12/23/2004US20040259939 Dissolving and precipitation a solution of citalopram in acid with solvent, adding base to liberate free base.
12/23/2004US20040259912 N-(4-benzhydryloxy-3-isobutyrylphenyl)-N'-(3,4-dimethoxyphenyl)urea for example; vanilloid receptor agonists; use as analgesic and or for treating urinary frequency and/or urinary incontinence
12/23/2004US20040259908 Integrin VLA-4 ( alpha 4 beta 1) and/or integrin LPAM-1 ( alpha 4 beta 7) antagonists, cell adhesion inhibitor; bioavailability, oral administration;treating inflammatory diseases; e.g. 3-[2-(2,6-dichlorobenzoylamino)pyrid-5-yl]-2-{3-[(2,2-dimethylpropionyl)isobutylamino]-4-methoxyphenyl}propionic acid
12/23/2004US20040259890 trans-3'-oxo-N-(trans-4-phenylcyclohexyl)-spiro[cyclohexane-1,1'(3'H)-isobenzofuran]-4-carboxamide e.g.; neuropeptide Y receptor antagonists for treatment of bulimia, obesity or diabetes for example
12/23/2004US20040259875 Incontinence; overactive bladder; neuropathic pain; neuralgia; analgesics; stroke; antiarthritic agents; antiinflammatory agents
12/23/2004US20040259804 (Substituted)Acyl dipeptidyl inhibitors of the ICE/ced-3 family of cysteine proteases
12/23/2004US20040256743 Replacing a halogen atom in organic compounds using as a catalyst a tris[tris(dialkylamino)- or tris(alkyleneamino)-phosphoranylideneamino]phosphine oxide or a phosphazenium derivative of the phosphine oxide
12/23/2004DE10324192A1 Verfahren zur Herstellung von alkoxylierten 2,5-Dihydrofuran-oder tetra-1,1,4,4-alkoxylierten But-2-enderivaten A process for the production of alkoxylated 2,5-dihydrofuran-or tetra-1,1,4,4-but-2-alkoxylated enderivaten
12/23/2004DE102004023605A1 New (pyrazol-4-yl)-(2,3-dihydro-benzofuran-4-yl or -benzothiophen-4-yl)-methanone derivatives, useful as pre- or post-emergence, total or selective herbicides or plant growth inhibitors
12/23/2004CA2528547A1 Saururus cernuus compounds that inhibit cellular responses to hypoxia
12/23/2004CA2526387A1 Benzamide derivative or salt thereof
12/22/2004EP1489106A1 Arene-ruthenium complexes immobilized on polymers, catalysts consisting of the complexes, and processes for organic syntheses with the same
12/22/2004EP1489078A1 Benzofuran derivative
12/22/2004EP1489077A1 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same
12/22/2004EP1489076A1 Cyclic hemiacetal derivative and use thereof
12/22/2004EP1487828A2 Morpholinyl-urea derivatives for use of the treatment of inflamatory diseases
12/22/2004EP1487813A1 Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders
12/22/2004EP1487812A1 Anomeric derivatives of monosaccharides
12/22/2004EP1487795A2 Synthesis of enantiomerically pure amino-substituted fused bicyclic rings
12/22/2004EP1487779A1 Oligofluorenylene compounds
12/22/2004EP1487577A1 Catalyst-precursor for the production of maleic acid anhydride and method for the production thereof
12/22/2004EP1487575A2 Method for the production of a catalyst containing vanadium, phosphorus, and oxygen
12/22/2004EP1487457A1 Combination of an il-1/18 inhibitor with a tnf inhibitor for the treatment of inflammation
12/22/2004EP1487430A1 Methods for treating diseases related to intraocular pressure
12/22/2004EP1487269A1 Autoinducer compounds
12/22/2004EP1133486B1 Nonsteroidal antiinflammatories
12/22/2004EP1086076B1 Sulfonamide inhibitors of aspartyl protease
12/22/2004EP1086072A4 Process for the preparation of protected dihydroxypropyl trialkylammonium salts and derivatives thereof
12/22/2004EP1080066A4 Bioreductive cytotoxic agents
12/22/2004CN1556800A Process for the preparation of citalopram
12/22/2004CN1556788A Muscarinic agonists
12/22/2004CN1181067C Benzofurans
12/22/2004CN1181050C Noval substituted dimeric compounds, its preparing process and medicinal composition containing same
12/22/2004CN1181020C Organic matter recovering and halogen acid refining process of industrial acid effluent containing halogen hydride
12/21/2004US6833460 Preparation and use of gamma-butyrolactones as cross-linking agents
12/21/2004US6833385 3-heteroarylalkyl substituted GABA analogs
12/21/2004US6833384 Deacetylase inhibitors
12/21/2004US6833200 Luminescent device with a triarylamine compound
12/21/2004US6833140 Orally administered dosage forms of GABA analog prodrugs having reduced toxicity
12/21/2004CA2147263C 4-alkoxy-2,6-di-t-butylphenol derivatives
12/16/2004WO2004108685A1 Aryl-heteroaromatic products, compositions containing same and use thereof
12/16/2004WO2004108673A2 Inhibitors of papilloma virus
12/16/2004WO2003063797A8 Cycloalkyl inhibitors of potassium channel function
12/16/2004US20040254385 Process for the preparation of citalopram hydrobromide
12/16/2004US20040254384 Production of 5-methyl-dihydro-furan-2-one from levulinic acid in supercritical media
12/16/2004US20040254327 Bisphenol a derivatives containing one biaryl group and a spacer; monomers for polycarbonates
12/16/2004US20040254249 Nonsteroidal antiinflammatory agents
12/16/2004US20040254235 homoserine lactone derivatives that stimulate or promote the metabolism, growth and/or recovery of microorganisms
12/16/2004US20040254167 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/16/2004CA2528093A1 Aryl-heteroaromatic products, compositions containing same and use thereof
12/16/2004CA2526506A1 Inhibitors of papilloma virus
12/15/2004EP1486492A2 A process for hydrogenolysis of [1-(3-dimethylamino)propyl)]-1-(4-fluorophenyl)-1,3-dihydro-5-halo-isobenzofuran.
12/15/2004EP1486491A1 Carboxyoic acid compounds and drugs containing the compounds as the active ingredient
12/15/2004EP1486479A1 Method for producing organic compounds by substituting halogen atoms
12/15/2004EP1486207A2 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
12/15/2004EP1485387A1 Carbamates as hiv protease inhibitors
12/15/2004EP1485370A1 Amino-derivatives as novel inhibitors of histone deacetylase
12/15/2004EP1485367A1 Purified citalopram salts
12/15/2004EP1485365A1 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
12/15/2004EP1485364A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
12/15/2004EP1485353A1 New inhibitors of histone deacetylase
12/15/2004EP1485348A1 Carbonylamino-derivatives as novel inhibitors of histone deacetylase
12/15/2004EP1485203A1 Catalyst-precursor for the production of maleic acid anhydride and method for the production thereof
12/15/2004EP1485099A1 Inhibitors of histone deacetylase
12/15/2004EP1485089A1 Combination treatments for chemokine-mediated diseases
12/15/2004EP1485079A2 Small molecule entry inhibitors
12/15/2004EP1263711B1 Novel use of phenylheteroalkylamine derivatives
12/15/2004EP1117639B1 Benzoylcyclohexandiones, method for the production and use thereof as herbicides and plant growth regulators
12/15/2004EP1115715B1 Method for producing tetrahydrofuran
12/15/2004CN1555371A Process for the preparation of 5-formyl-2- benzo[c]usfuran ketone